Press Releases

Date Title and Summary
Toggle Summary Accuray Incorporated Ranked 55th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500
Company's 5,000 Percent Five-Year Revenue Growth Receives National Acclaim SUNNYVALE, Calif., Nov. 17 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it ranked 55th on Deloitte's 2008 Technology Fast 500, a ranking of
Toggle Summary Accuray Postpones Release of First Quarter Fiscal 2009 Results
Conference Call to be Rescheduled SUNNYVALE, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that in conjunction with its independent auditors and legal advisors, the Company is further reviewing financial
Toggle Summary Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
Attributes its 5,000 Percent Revenue Growth from FY03-FY07 to Increased CyberKnife Acceptance SUNNYVALE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), has been named to Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment and
Toggle Summary Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
Conference Call Postponed Until November 6, 2008 SUNNYVALE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it is rescheduling the earnings release call to November 6, 2008 when Accuray will release
Toggle Summary Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
SUNNYVALE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 19th Annual Oppenheimer Healthcare Conference in New York, on Tuesday, November 4, 2008 at 10:00
Toggle Summary CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008
Full Body Radiosurgery Expands Treatment Options for Patients with Lung, Prostate, Liver and Pancreatic Cancer SUNNYVALE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that treatments of extracranial
Toggle Summary Next Generation CyberKnife System Cuts Prostate Cancer Treatment Times in Half at CyberKnife Centers of San Diego
Technological Advancements Enable Highly-Complex Treatments to be Delivered in Routine Clinical Practice SUNNYVALE, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that CyberKnife Centers of San Diego has
Toggle Summary First CyberKnife System Purchased in Latin America
System to be Installed in Venezuela SUNNYVALE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that Domingo Luciani Hospital has purchased a CyberKnife(R) Robotic Radiosurgery System for installation at
Toggle Summary Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its first quarter fiscal year 2009, ending September 27, 2008, on Wednesday, October 29, 2008 after the market
Toggle Summary First CyberKnife in Saudi Arabia to be Installed at Prestigious King Faisal Specialist Hospital and Research Center
SUNNYVALE, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first CyberKnife(R) Robotic Radiosurgery System in the Kingdom of Saudi Arabia will be installed at the prestigious King Faisal Specialist

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.